SEC Filings for Cannabics Pharmaceuticals Inc (CNBX)

$ 0.2725   -0.00981 (-3.47%) Volume: 78.14k 3:59 PM EDT 29-May-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)302/14/2018
8-KCurrent report pursuant to Section 13 or 15(d)401/30/2018
10-QGeneral form for quarterly reports under Section 13 or 15(d)5101/16/2018
8-KCurrent report pursuant to Section 13 or 15(d)712/19/2017
10-KAnnual report pursuant to Section 13 or 15(d)7412/08/2017
NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405211/29/2017
8-KCurrent report pursuant to Section 13 or 15(d)311/13/2017
8-KCurrent report pursuant to Section 13 or 15(d)311/13/2017
10-QGeneral form for quarterly reports under Section 13 or 15(d)4307/17/2017
424B5Prospectus [Rule 424(b)(5)]2905/10/2017
8-KCurrent report pursuant to Section 13 or 15(d)3405/10/2017
10-QGeneral form for quarterly reports under Section 13 or 15(d)4104/14/2017
S-3/A[Amend] Registration statement under Securities Act of 19332404/07/2017
123456789101112131415